BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2039258)

  • 1. Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation.
    Rawlinson PS; Green RH; Coggins AM; Boyle IT; Gibson BE
    Arch Dis Child; 1991 May; 66(5):638-9. PubMed ID: 2039258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia and altered biochemical bone markers in post-bone marrow transplantation osteopetrosis: a case report and literature review.
    Kulpiya A; Mahachoklertwattana P; Pakakasama S; Hongeng S; Poomthavorn P
    Pediatr Transplant; 2012 Aug; 16(5):E140-5. PubMed ID: 21323826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantation.
    Dini G; Floris R; Garaventa A; Oddone M; De Stefano F; De Marco R; Calcagno E; Faraci M; Claudiani F; Manfredini L; Dallorso S; Lanino E; Morreale G
    Bone Marrow Transplant; 2000 Jul; 26(2):219-24. PubMed ID: 10918435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
    Kutluk MT; Hazar V; Akyüz C; Varan A; Büyükpamukçu M
    J Pediatr; 1997 May; 130(5):828-31. PubMed ID: 9152297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypercalcaemia of malignancy.
    Heath DA
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination therapy with pamidronate and calcitonin in hypercalcemic crisis caused by primary hyperparathyroidism].
    Christensen JH; Kristiansen JH
    Ugeskr Laeger; 1992 Nov; 154(47):3341-2. PubMed ID: 1462441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.
    McIntyre HD; Cameron DP; Urquhart SM; Davies WE
    Postgrad Med J; 1989 Apr; 65(762):244-6. PubMed ID: 2594602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of malignant hypercalcaemia.
    Watters J; Gerrand G; Dodwell D
    Drugs; 1996 Dec; 52(6):837-48. PubMed ID: 8957154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
    Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy.
    Gurney H; Kefford R; Stuart-Harris R
    Lancet; 1989 Jul; 2(8657):241-4. PubMed ID: 2569054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.
    Varache N; Audran M; Clochon P; Lortholary A; Bouachour G; Alquier P; Basle MF
    Clin Rheumatol; 1991 Sep; 10(3):328-32. PubMed ID: 1790647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
    Williams CJ; Smith RA; Ball RJ; Wilkinson H
    Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment.
    Gibbs CJ; Peacock M
    Postgrad Med J; 1986 Oct; 62(732):937-8. PubMed ID: 3774726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful bone-marrow transplantation for infantile malignant osteopetrosis.
    Coccia PF; Krivit W; Cervenka J; Clawson C; Kersey JH; Kim TH; Nesbit ME; Ramsay NK; Warkentin PI; Teitelbaum SL; Kahn AJ; Brown DM
    N Engl J Med; 1980 Mar; 302(13):701-8. PubMed ID: 6986555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tolerability of drug therapies for hypercalcaemia of malignancy.
    Zojer N; Keck AV; Pecherstorfer M
    Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
    MacConnachie AM
    Intensive Crit Care Nurs; 1997 Feb; 13(1):58-9. PubMed ID: 9095884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.